Branch P, Aquilina G, Bignami M, Karran P
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts, UK.
Nature. 1993 Apr 15;362(6421):652-4. doi: 10.1038/362652a0.
Acquired resistance to alkylating agents such as N-methyl-N-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine results from the ability to tolerate the potentially cytotoxic methylated base O6-methylguanine (m6-G) in DNA. In the absence of repair by demethylation in situ, m6-G is probably lethal through its inappropriate processing by the cell. DNA mismatch correction is an attractive candidate for the processing function because although it is replicated, m6-G has no perfect complementary base. Thus, m6-G in DNA might provoke abortive mismatch repair and tolerance could subsequently arise through loss of a mismatch repair pathway. Mismatch correction helps maintain genomic fidelity by removing misincorporated bases and deaminated 5-methylcytosine from DNA, and its loss by mutation confers a mutator phenotype on Escherichia coli. Here we describe human and hamster cell lines that are tolerant to N-methyl-N-nitrosourea and are defective in a DNA mismatch binding activity. The loss of this activity, which acts on G.T mispairs, confers a mutator phenotype.
对诸如N-甲基-N-亚硝基脲或N-甲基-N'-硝基-N-亚硝基胍等烷化剂产生获得性抗性,是由于细胞能够耐受DNA中具有潜在细胞毒性的甲基化碱基O6-甲基鸟嘌呤(m6-G)。在缺乏原位去甲基化修复的情况下,m6-G可能因其被细胞不恰当处理而具有致死性。DNA错配修复是处理功能的一个有吸引力的候选机制,因为尽管m6-G可以被复制,但它没有完美的互补碱基。因此,DNA中的m6-G可能引发流产性错配修复,随后通过错配修复途径的丧失而产生耐受性。错配修复通过从DNA中去除错配掺入的碱基和脱氨基的5-甲基胞嘧啶来帮助维持基因组保真度,其因突变而丧失会赋予大肠杆菌一种突变表型。在此,我们描述了对N-甲基-N-亚硝基脲耐受且DNA错配结合活性有缺陷的人类和仓鼠细胞系。这种作用于G.T错配的活性丧失赋予了一种突变表型。